Skip to search formSkip to main contentSkip to account menu

RVX 000222

Known as: RVX-000222, RVX000222 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

RVX 208

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Novel Drugs Targeting the Epigenome
Epigenetic drug discovery has its beginning in the cancer research arena, focusing first on DNA methylation and histone… 
Review
2011
Review
2011
RVX 208
RVX 208 (RVX-208; RVX000222) is a first-in-class novel small molecule in development by Resverlogix Corporation for acute… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)